Abstract:Background/Aims: Transplantation of endothelial progenitor cells (EPCs) plays a therapeutic role in pulmonary arterial hypertension (PAH). Meanwhile, recruitment of progenitors has potential inflammatory effects and exaggerates vascular injury. CD40 pathway is identified as a major player in vascular inflammatory events. In this study, we investigated the role of CD40 pathway in regulating early outgrowth EPC functions, and searched for improvements in PAH cell therapy. Methods: EPCs were isolated from rat bone marrow and cultured for 7 days. After treatment with soluble CD40 ligand (sCD4OL) for 24 hours, EPC migration, adhesion, proliferation, paracrine and vasculogenesis functions were tested. Rat PAH model was founded by subcutaneous injection of monocrotaline (MCT). Control EPCs or lentivirus vectors (Lv)-shRNA-CD40 EPCs were infused via tail vein at day 7, 14, and 21 after MCT injection. Therapeutic effects were evaluated at day 28. Results: sCD4OL dose-dependently impaired EPC migration, adhesion, proliferation, and vasculogenesis functions. However, paracrine effects of soluble intercellular adhesion molecule-1, vascular endothelial growth factor and interleukin-6 were dose-dependently improved by sCD4OL. Control EPC-derived conditioned medium protected endothelial cell in vitro vasculogenesis, while sCD40L-pretreated ones showed detrimental effects. After MCT injection, sCD4OL levels in rat serum increased gradually. Other than in vitro results, benefits of both two EPC treatments were obvious, even taken at day 21. Benefits of control EPCs wore off over time, but those of Lv-shRNA-CD40 EPCs were more effective and enduring, as characterized by both ameliorated rat hemodynamic and reversed vascular remodeling. Furthermore, Lv-shRNA-CD40 EPCs integrated into endothelium better, rather than into adventitia and media. Conclusion: sCD4OL impaired protective effects of EPCs. Traditional EPC treatments were limited in PAH, while interruption of CD40 pathway of transplanted cells could apparently improve the therapeutic efficacy. Copyright (C) 2015 S Karger AG, Basel

CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension.

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

CYP2J2 Overexpression Increases EETs and Protects Against Angiotensin II-induced Abdominal Aortic Aneurysm in Mice

Eets Alleviate Ox-Ldl-Induced Inflammation by Inhibiting Lox-1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells

Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-β1-Smad2/3 Signaling in a PPARγ-Dependent Manner.

Intratracheal Instillation of Ethyl Pyruvate Nanoparticles Prevents the Development of Shunt-Flow-induced Pulmonary Arterial Hypertension in a Rat Model

P2X7 Receptor is Involved in Lung Injuries Induced by Ischemia-Reperfusion in Pulmonary Arterial Hypertension Rats

Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis

15-oxo-Eicosatetraenoic acid prevents serum deprivation-induced apoptosis of pulmonary arterial smooth muscle cells by activating pro-survival pathway.

Cytochrome P-450 Epoxygenases Protect Endothelial Cells from Apoptosis Induced by Tumor Necrosis Factor-Alpha Via Mapk and Pi3k/Akt Signaling Pathways

Sex- and Isoform-Specific Mechanism of Neuroprotection by Transgenic Expression of P450 Epoxygenase in Vascular Endothelium

CYP2J2 promotes the development of hepatocellular carcinoma by increasing the EETs production to improve HIF-1 stability

Ethyl pyruvate ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.

Expression of Epoxygenases Belonging to Cyp2 Family in Rat Myocardial Ischemia/Reperfusion Injury in Vivo

Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling

Arachidonic Acid Cytochrome P450 Epoxygenases Protect Vessel Endothelial Cells Against Apoptosis Induced by Tumor Necrosis Factor-Α

Effects of ethyl pyruvate in the treatment of hyperkinetic pulmonary hypertension

Role of 20-Hydroxyeicosatetraenoic Acid in Pulmonary Hypertension and Proliferation of Pulmonary Arterial Smooth Muscle Cells.

The role of ERK1/2 in 15-HETE-inhibited apoptosis in pulmonary arterial smooth muscle cells.